Literature DB >> 24387797

Cephalometric assessment of craniofacial dysmorphologies in relation with Msx2 mutations in mouse.

Y Simon1, A Marchadier, M K Riviere, K Vandamme, F Koenig, F Lezot, A Trouve, C L Benhamou, J L Saffar, A Berdal, J R Nefussi.   

Abstract

OBJECTIVES: To determine the role of Msx2 in craniofacial morphology and growth, we used a mouse model and performed a quantitative morphological characterization of the Msx2 (-/-) and the Msx2 (+/-) phenotype using a 2D cephalometric analysis applied on micrographs.
MATERIALS AND METHODS: Forty-four three-and-a-half-month-old female CD1 mice were divided into the following three groups: Msx2 (+/+) (n = 16), Msx2 (+/-) (n = 16), and Msx2 (-/-) (n = 12). Profile radiographs were scanned. Modified cephalometric analysis was performed to compare the three groups.
RESULTS: Compared with the wild-type mice, the Msx2 (-/-) mutant mice presented an overall craniofacial size decrease and modifications of the shape of the different parts of the craniofacial skeleton, namely the neurocranium, the viscerocranium, the mandible, and the teeth. In particular, dysmorphologies were seen in the cochlear apparatus and the teeth (taurodontism, reduced incisor curvature). Finally contrary to previous published results, we were able to record a specific phenotype of the Msx2 (+/-) mice with this methodology. This Msx2 (+/-) mouse phenotype was not intermediate between the Msx2 (-/-) and the wild-type animals.
CONCLUSION: Msx2 plays an important role in craniofacial morphogenesis and growth because almost all craniofacial structures were affected in the Msx2(-/-) mice including both intramembranous and endochondral bones, the cochlear apparatus, and the teeth. In addition, Msx2 haploinsufficiency involves a specific phenotype with subtle craniofacial structures modifications compared with human mutations.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  2D cephalometric analysis; Msx2; animal model; craniofacial morphology; microradiograph

Mesh:

Substances:

Year:  2014        PMID: 24387797     DOI: 10.1111/ocr.12035

Source DB:  PubMed          Journal:  Orthod Craniofac Res        ISSN: 1601-6335            Impact factor:   1.826


  6 in total

Review 1.  MSX2 in ameloblast cell fate and activity.

Authors:  Sylvie Babajko; Muriel de La Dure-Molla; Katia Jedeon; Ariane Berdal
Journal:  Front Physiol       Date:  2015-01-05       Impact factor: 4.566

2.  Postnatal Craniofacial Skeletal Development of Female C57BL/6NCrl Mice.

Authors:  Xiaoxi Wei; Neil Thomas; Nan E Hatch; Min Hu; Fei Liu
Journal:  Front Physiol       Date:  2017-09-14       Impact factor: 4.566

3.  The crest phenotype in domestic chicken is caused by a 197 bp duplication in the intron of HOXC10.

Authors:  Jingyi Li; Mi-Ok Lee; Brian W Davis; Ping Wu; Shu-Man Hsieh Li; Cheng-Ming Chuong; Leif Andersson
Journal:  G3 (Bethesda)       Date:  2021-02-09       Impact factor: 3.154

4.  The CMS19 disease model specifies a pivotal role for collagen XIII in bone homeostasis.

Authors:  A V Kemppainen; M A Finnilä; A Heikkinen; H Härönen; V Izzi; S Kauppinen; S Saarakkala; T Pihlajaniemi; J Koivunen
Journal:  Sci Rep       Date:  2022-04-07       Impact factor: 4.379

5.  Maternal Microbiota Modulate a Fragile X-like Syndrome in Offspring Mice.

Authors:  Bernard J Varian; Katherine T Weber; Lily J Kim; Tony E Chavarria; Sebastian E Carrasco; Sureshkumar Muthupalani; Theofilos Poutahidis; Marwa Zafarullah; Reem R Al Olaby; Mariana Barboza; Kemal Solakyildirim; Carlito Lebrilla; Flora Tassone; Fuqing Wu; Eric J Alm; Susan E Erdman
Journal:  Genes (Basel)       Date:  2022-08-08       Impact factor: 4.141

6.  The absence of muscle segment homeobox 2 leads to the pyroptosis of ameloblasts by inducing squamous epithelial hyperplasia in the enamel organ.

Authors:  Juanjuan Zhang; Ying Xu; Ying Zhao; Jingkun Bai; Mengge Xu; Chuanji Li; Jinyue Li; Yong Ren; Chang Xu; Yuguang Gao; Yan Sun; Xiaoying Liu
Journal:  J Cell Mol Med       Date:  2021-05-26       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.